Featured News
630Wire Storiesindie Semiconductor Establishes Sales and Technical Support Center of Excellence in Japan
Expands Global Footprint into a Geographically Strategic Automotive Market Provides Local Customer Support for indie Autotech Solutions Plans to Participate in Upcoming...
- 820Wire Stories
Ness Strengthens Product Engineering Expertise With the Acquisition of Niyuj
TEANECK, N.J.–(BUSINESS WIRE)–Ness, a full-lifecycle digital services transformation company, is pleased to announce its acquisition of Niyuj, a leading provider of software...
- 586Wire Stories
AffaMed Therapeutics, licensee of DEXTENZA® in Certain Asian Markets, Doses Their First Patient in Clinical Trial Evaluating the Safety and Efficacy of DEXTENZA® in China in Cataract Surgery Patients
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases...
- 694Wire Stories
New Zealand Domain Name Commission Selects Dialpad for Contact Centre Operations
Dialpad unified communications platform connects organisations with global customers AUCKLAND, New Zealand–(BUSINESS WIRE)–Dialpad Inc., the industry leader in AI-powered communication and collaboration,...
- 615Wire Stories
Advent Technologies to supply SereneU Fuel Cells for Globe Telecom’s rooftop sites in the Philippines
BOSTON–(BUSINESS WIRE)–Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent“ or the “Company”), an innovation-driven leader in the fuel cell and hydrogen technology space,...
- 601Wire Stories
Fabrinet to Announce Second Quarter 2022 Financial Results on January 31, 2022
BANGKOK–(BUSINESS WIRE)–#EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment...
- 586Wire Stories
Daiichi Sankyo to Divest Certain Cardiovascular and Other Legacy Products to Cosette Pharmaceuticals in the United States, Shifting Focus to Oncology Portfolio
Agreement is part of Daiichi Sankyo’s five-year mid-term strategy to transform to a structure primarily focused on patented drugs TOKYO & BASKING...
- 606Wire Stories
Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage...
- 692Wire Stories
PortalGuard Identity & Access Management (IAM) Platform Chosen by Lawrence County, South Dakota for Frictionless Cyber Security & Insurance Compliance
WALL, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and...
- 619Wire Stories
Gilat to Report Fourth Quarter and Full Year 2021 Results on February 15th
PETAH TIKVA, Israel, Jan. 18, 2022 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite...
- 606Wire Stories
TandemAI Announces Expansion of Senior Leadership Team
Albert Pan, Ph.D., named Chief Technology Officer Lanny Sun appointed Board Chairman NEW YORK & SUZHOU & SHANGHAI, China–(BUSINESS WIRE)–TandemAI, a technology...
